Security key
427746102
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)
CUSIP: 427746102
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 182,615,507
- Total 13F shares
- 114,941,581
- Share change
- -6,938,779
- Total reported value
- $175,829,179
- Put/Call ratio
- 1.6%
- Price per share
- $1.53
- Number of holders
- 161
- Value change
- -$13,146,397
- Number of buys
- 61
- Number of sells
- 82
Report period
Q4 2024
Institutions
161
Top holders
10
HRTX full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
HERON THERAPEUTICS, INC. /DE/ SEC filings
HERON THERAPEUTICS, INC. /DE/ company facts
Broader feeds
Reporting periods
Holder history for CUSIP 427746102
Recent filing periods:
Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rubric Capital Management LP |
13F
|
Company |
15%
|
26,713,503
|
$53,159,871 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
4.8%
|
8,850,000
|
$17,611,500 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.8%
|
8,720,176
|
$17,353,150 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
4.7%
|
8,534,567
|
$16,983,790 | — | 30 Sep 2024 | |
| Velan Capital Investment Management LP |
13F
3/4/5
|
Company · Other* |
3.8%
|
6,986,744
|
$13,903,621 | — | 30 Sep 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
2.9%
|
5,305,816
|
$10,558,574 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.4%
|
4,384,677
|
$8,725,507 | — | 30 Sep 2024 | |
| PALISADE CAPITAL MANAGEMENT, LP |
13F
|
Company |
2.2%
|
3,992,278
|
$7,944,633 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
3,192,436
|
$6,352,948 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
3,045,361
|
$6,061,701 | — | 30 Sep 2024 | |
| JW Asset Management, LLC |
13F
|
Company |
1.3%
|
2,292,418
|
$4,561,912 | — | 30 Sep 2024 | |
| Clearline Capital LP |
13F
|
Company |
1.2%
|
2,226,512
|
$4,430,759 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
2,008,198
|
$3,996,314 | — | 30 Sep 2024 | |
| Orchard Capital Management, LLC |
13F
|
Company |
1.1%
|
1,980,198
|
$3,949,462 | — | 30 Sep 2024 | |
| Congress Park Capital LLC |
13F
|
Company |
1.1%
|
1,978,078
|
$3,936,376 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
1,850,000
|
$3,681,500 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.97%
|
1,768,353
|
$3,519,022 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.94%
|
1,715,545
|
$3,413,936 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.93%
|
1,707,152
|
$3,397,232 | — | 30 Sep 2024 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.92%
|
1,678,417
|
$3,340,050 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.87%
|
1,591,547
|
$3,167,179 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.77%
|
1,402,075
|
$2,790,129 | — | 30 Sep 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.7%
|
1,279,944
|
$2,547,089 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.63%
|
1,146,658
|
$2,281,849 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.61%
|
1,106,696
|
$2,202,325 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
1,096,385
|
$2,181,806 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
989,987
|
$1,970,074 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.52%
|
955,928
|
$1,902,296 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.51%
|
934,388
|
$1,859,432 | — | 30 Sep 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.49%
|
900,107
|
$1,791,213 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.44%
|
811,371
|
$1,614,628 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.34%
|
612,897
|
$1,219,665 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.28%
|
512,736
|
$1,020,000 | — | 30 Sep 2024 | |
| Richmond Brothers, Inc. |
13F
|
Company |
0.28%
|
510,782
|
$1,016,456 | — | 30 Sep 2024 | |
| CM Management, LLC |
13F
|
Company |
0.27%
|
500,000
|
$995,000 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.27%
|
496,227
|
$987,491 | — | 30 Sep 2024 | |
| NEXPOINT ASSET MANAGEMENT, L.P. |
13F
|
Company |
0.26%
|
475,750
|
$946,743 | — | 30 Sep 2024 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.26%
|
475,575
|
$946,395 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.24%
|
431,906
|
$859,493 | — | 30 Sep 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.23%
|
426,817
|
$849,000 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
340,739
|
$678,072 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.18%
|
332,126
|
$660,930 | — | 30 Sep 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.16%
|
297,568
|
$592,160 | — | 30 Sep 2024 | |
| KBC Group NV |
13F
|
Company |
0.16%
|
289,269
|
$576,000 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.15%
|
275,946
|
$549,133 | — | 30 Sep 2024 | |
| Apeiron RIA LLC |
13F
|
Company |
0.13%
|
243,542
|
$484,649 | — | 30 Sep 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.12%
|
220,834
|
$439,460 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.12%
|
218,455
|
$434,726 | — | 30 Sep 2024 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0.12%
|
213,630
|
$425,124 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.11%
|
206,711
|
$411,355 | — | 30 Sep 2024 |
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q4 2024
As of 31 Dec 2024,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
114,941,581 shares.
The largest 10 holders included
Rubric Capital Management LP, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Velan Capital Investment Management LP, Tejara Capital Ltd, PALISADE CAPITAL MANAGEMENT, LP, D. E. Shaw & Co., Inc., STATE STREET CORP, and Point72 Asset Management, L.P..
This page lists
161
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
169
Q4 2024 holders
161
Holder diff
-8
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.